Trademark: 88672961
Status Date
Tuesday, November 1, 2022
Registration Number
6890002
Registration Date
Tuesday, November 1, 2022
Filing Date
Tuesday, October 29, 2019
Published for Opposition
Tuesday, March 10, 2020
5 Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism
Nov 1, 2022
Notice Of Registration Confirmation Emailed
Nov 1, 2022
Registered-Principal Register
Sep 30, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 29, 2022
Allowed Principal Register - Sou Accepted
Sep 29, 2022
Statement Of Use Processing Complete
Sep 15, 2022
Use Amendment Filed
Sep 29, 2022
Case Assigned To Intent To Use Paralegal
Sep 15, 2022
Teas Statement Of Use Received
Apr 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2022
Sou Extension 4 Granted
Apr 27, 2022
Sou Extension 4 Filed
Apr 27, 2022
Teas Extension Received
Jan 3, 2022
Assigned To Examiner
Nov 6, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 4, 2021
Sou Extension 3 Granted
Nov 4, 2021
Sou Extension 3 Filed
Nov 4, 2021
Teas Extension Received
May 4, 2021
Notice Of Approval Of Extension Request E-Mailed
May 2, 2021
Sou Extension 2 Granted
May 2, 2021
Sou Extension 2 Filed
May 2, 2021
Teas Extension Received
Nov 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2020
Sou Extension 1 Granted
Nov 5, 2020
Sou Extension 1 Filed
Nov 5, 2020
Teas Extension Received
May 5, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 10, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 10, 2020
Published For Opposition
Feb 19, 2020
Notification Of Notice Of Publication E-Mailed
Feb 4, 2020
Approved For Pub - Principal Register
Feb 3, 2020
Assigned To Examiner
Nov 2, 2019
New Application Office Supplied Data Entered In Tram
Nov 1, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
